Detalhe da pesquisa
1.
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(12): 1441-1464, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902832
2.
A Phase II Trial of Selinexor (KPT-330) for Metastatic Triple-Negative Breast Cancer.
Oncologist
; 24(7): 887-e416, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996012
3.
Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.
Curr Treat Options Oncol
; 19(8): 39, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29931587
4.
Treatment of the Pregnant Patient with Breast Cancer.
South Med J
; 110(10): 627-631, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28973702
5.
Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies.
Biol Blood Marrow Transplant
; 20(2): 257-63, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24269380
6.
Safety Monitoring Activity During EGFR or Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients With Lung Cancer.
JCO Oncol Pract
; 19(6): 345-351, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075260
7.
Enhanced Efficacy of Chemotherapy by Addition of Immune Checkpoint Inhibitors in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung: A Real-World Analysis.
J Cancer
; 14(17): 3169-3175, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37928431
8.
Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutation.
J Thorac Dis
; 15(11): 6115-6125, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38090314
9.
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations.
Lung Cancer
; 183: 107313, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499521
10.
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 116(4): 837-848, 2023 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657497
11.
Rapid Improvement Following Receipt of Infliximab in Steroid-refractory Durvalumab-Associated Grade 3 Pneumonitis.
Cureus
; 14(2): e22295, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35350507
12.
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res
; 27(13): 3630-3640, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33820783
13.
Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 109(2): 425-435, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002543
14.
Combination checkpoint inhibitors for treatment of non-small-cell lung cancer: an update on dual anti-CTLA-4 and anti-PD-1/PD-L1 therapies.
Drugs Context
; 92020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32158484
15.
Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC).
Front Oncol
; 10: 1074, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766139
16.
Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer.
Expert Opin Biol Ther
; 19(3): 225-232, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30657338
17.
Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer.
Clin Cancer Res
; 25(22): 6623-6632, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409616
18.
Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer.
Cancer Manag Res
; 10: 931-940, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29760563
19.
Infectious complications in living-donor kidney transplant recipients undergoing multi-modal desensitization.
Surg Infect (Larchmt)
; 15(3): 182-6, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24773230